NASDAQ · NUWEHealthcareElectromedical Equipment

Nuwellis financials

$0.7459−1.88%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$8.3M$8.7M$8.9M$8.5M$7.9M
Gross profit$5.1M$5.7M$5.0M$4.8M$4.5M
Gross margin62.0%64.9%56.2%55.7%56.7%
Operating income-$11.1M-$11.0M-$17.6M-$17.2M-$19.5M
Net income-$17.5M-$10.6M-$20.2M-$14.5M-$19.6M
Net margin−211.8%−121.6%−228.0%−170.0%−247.7%
Diluted EPS$-888.65$-12365.50$-529288.20$-4298647.50$-14681772.00
EBITDA-$10.9M-$10.7M-$17.3M-$16.8M-$19.0M
Operating cash flow-$10.8M-$9.6M-$17.9M-$15.1M-$17.8M
Free cash flow-$10.9M-$9.7M-$18.1M-$15.3M-$18.1M
Diluted shares0.0M0.0M0.0M0.0M0.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$1.1M$5.1M$3.8M$17.7M$8.7M
Short-term investments$0.00$0.00$0.00$569.0K$15.5M
Total debt$0.00$0.00$0.00$28.0K$54.0K
Total assets$6.1M$9.9M$9.8M$24.7M$30.4M
Total liabilities$3.5M$3.3M$6.6M$12.3M$4.5M
Shareholders' equity$2.6M$6.5M$3.0M$12.4M$25.9M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology